To empower the global healthcare ecosystem through innovation

Predicine is a molecular insight company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. Our biology-oriented approach to analyzing genomics is advancing the understanding of tumor mutational landscape.

Our passion

At Predicine, we are passionate about our people, technology, and creating a lasting impact in cancer research. 



Passionate, fearless and committed talent is our key strength. 35% of our team are PhDs.



We are leading the innovation in urine-based diagnostics.


Profound impact

Helping patients worldwide in clinical trials and easy cancer detection.

Our values and culture

Predicine is the culmination of talented people coming together to realize a shared vision. Our culture is dynamic, fast-paced, energetic and innovative. We innovate boldly and have an endless pursuit for quality. We stick by our values to carry out our important roles because we know that the work we do every day impacts real lives.


  • Integrity
  • Innovation
  • Quality
  • Respect
  • Courage
  • Collaboration
  • Caring
  • Communication


Shidong Jia | CEO

Shidong Jia, MD, PhD, is the Founder and CEO of Predicine. Prior to founding Predicine, Shidong spearheaded the oncology biomarker strategies and drug & diagnostics co-development at Genentech. His previous work identified p110beta as novel drug target for PTEN-deficient tumors, a finding that laid the foundation for clinical development and testing of p110beta inhibitors in cancers. He previously held various senior research positions focusing on translational and clinical cancer research at Novartis Institutes for BioMedical Research and Harvard University. Shidong was awarded the P.A.R.T. Investigatorship Award from the Dana-Farber Cancer Institute. Shidong holds a MD and PhD from Harbin Medical University and Peking Union Medical College, and completed postdoctoral training at the Dana-Farber Cancer Institute – Harvard University.

Pan Du | President

Pan Du, PhD, is the Co-founder, President and CTO at Predicine. Pan is an expert in next-generation sequencing, bioinformatics, and oncology diagnostics. He has developed multiple widely used bioinformatics analysis software and has authored numerous publications, including several 1st authorship manuscripts that are cited over thousands times. Prior to Predicine, Pan was Principal Scientist at Roche Diagnostics and Senior Computational Biologist at Genentech. He was previously an Assistant Professor at Biomedical Informatics Center at Northwestern University. Pan holds a PhD with distinction in both Bioinformatics and Electrical Engineering from Iowa State University.

Dennis Merkle | President

Dennis Merkle, PhD, MBA, is the Global Head of Biopharma Business and CEO of Predicine Europe. Dennis has over 20 years’ experience in Precision Oncology, having held numerous positions across both commercial and R&D functions in the pharmaceutical and diagnostics industries. Most recently he served as senior vice president of corporate development, oncology development strategy and alliance management at Invitae (formerly ArcherDx). Prior to that, Dennis was the global head of market enabling technologies and companion diagnostics at Merck KGaA, where he over-saw the development of numerous companion diagnostics across the entire Merck KGaA drug pipeline. Dennis was awarded an Alexander von Humboldt fellowship for his post-doctoral work at the Technical University of Dresden, Germany and obtained his BSc and PhD in Chemistry from the University of Calgary, Canada, focusing on DNA double-strand break repair mechanisms. Dennis also holds an MBA from Durham University Business School, UK.


Join the fight against cancer

If you enjoy challenges, collaborating with others to solve complex problems, and the chance to see your work impact the millions of lives touched by cancer, this is the place to be.


• Healthy catered lunches
• Premium snacks and beverages
• Ample employee parking
• Happy hours and quarterly team building events 
• Close to 92 Bridge, easy access to HWY 880

Open Positions

Bonus for referrals and new hires are paid 90 days after hire*

News & Events


Our molecular genetics lab

We have a CAP-accredited and CLIA-certified laboratory in Hayward, California that uses the most cutting-edge technologies and instruments including Illumina MiniSeq™, Illumina NextSeq™, and Illumina NovaSeq™ 6000 System.   Our high-caliber laboratory staff bring a wealth of sequencing and sample expertise to ensure accuracy and reliability of results.

Predicine’s licenses and accreditations:

3555 Arden Road, Hayward CA 94545

  • CAP: 8169662
  • CLIA: 05D2148483
  • State of California: CDF-00351747
  • State of Maryland: 2906
  • State of Rhode Island: LCO01259
  • State of Pennsylvania: 36601
  • State of New York: PFI 9740

3555 Arden Road, Hayward CA 94545

  • CAP: 9327228
  • CLIA: 05D2258469
  • State of California: CDF-90006452

15366 Park Row, Houston TX 77084

  • CAP: 9307089
  • CLIA: 45D2260063

1314 North Plum Grove Road, Schaumburg IL 60173

  • CAP: 9307136
  • CLIA: 14D2256972

Contact us

If you have any questions or need assistance, our customer support team is on-hand to help.




3555 Arden Road
Hayward, CA 94545, USA


1698 Wangyuan Road, Building 11
Shanghai, 201499, China

Get in touch

We would love to hear from you. Please use the form below to submit your questions, comments, or inquries about potential partnerships.